XML 39 R25.htm IDEA: XBRL DOCUMENT v3.6.0.2
Summary of Significant Accounting Policies (Tables)
12 Months Ended
Dec. 31, 2016
Summary of Significant Accounting Policies  
Schedule of cash and cash equivalents

Cash and cash equivalents consist of the following (in thousands):

 

                                                                                                                                                                                    

 

 

December 31,

 

 

 

2016

 

2015

 

Cash

 

$

1,173 

 

$

776 

 

Money market fund

 

 

22,423 

 

 

62,004 

 

​  

​  

​  

​  

Total

 

$

23,596 

 

$

62,780 

 

​  

​  

​  

​  

​  

​  

​  

​  

 

Schedule of stock-based compensation expense

        During the years ended December 31, 2016, 2015 and 2014, the Company recorded stock-based compensation expense for employee and non-employee stock options and restricted stock, which was allocated as follows in the statements of operations (in thousands):

                                                                                                                                                                                    

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

Research and development

 

$

723 

 

$

681 

 

$

434 

 

General and administrative

 

 

1,437 

 

 

977 

 

 

463 

 

​  

​  

​  

​  

​  

​  

Total

 

$

2,160 

 

$

1,658 

 

$

897 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

 

Schedule of anti-dilutive common stock equivalents excluded from calculation of diluted net loss per share

                                                                                                                                                                                    

 

 

Year Ended December 31,

 

 

 

2016

 

2015

 

2014

 

Convertible preferred stock

 

 

 

 

 

 

8,012,988 

 

Stock options

 

 

2,270,169 

 

 

1,723,554 

 

 

1,226,140 

 

Common stock warrants

 

 

24,566 

 

 

59,405 

 

 

34,839 

 

Preferred stock warrants

 

 

 

 

 

 

12,283 

 

​  

​  

​  

​  

​  

​  

 

 

 

2,294,735 

 

 

1,782,959 

 

 

9,286,250 

 

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​  

​